Abstract
Biomedical research cannot succeed without funding, knowledgeable staff, and appropriate infrastructure. There are however equally important but intangible factors that are rarely considered in planning large multidisciplinary endeavors or evaluating their success. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial required extensive collaborations between individuals from many fields, including clinicians, clinical trialists, and administrators; it also addressed questions across the spectrum of cancer prevention and control. In this manuscript, we examine the experiences and opinions of trial staff regarding the building of successful relationships in PLCO. We summarize, in narrative form, data collected using open-ended questionnaires that were administered to the National Cancer Institute project officers, coordinating center staff, screening center principal investigators, and screening center coordinators in 2015, about 3 years after publication of the final primary trial manuscript. Trust, respect, listening to others, and in-person interaction were frequently mentioned as crucial to building successful relationships.
Keywords: Cancer screening, collaboration, multidisciplinary, PLCO, randomized controlled trials as subject, team science.
Reviews on Recent Clinical Trials
Title:Building Successful Relationships in the PLCO Cancer Screening Trial
Volume: 10 Issue: 3
Author(s): Victoria Jenkins, Susan Yurgalevitch, Lance A. Yokochi, Vicki Shambaugh, Douglas Reding, Philip C. Prorok, Sheryl L. Ogden, Barbara O’Brien, Karen Lappe, Christine C. Johnson, Pamela M. Marcus, Rachel Jaggi, Darlene Higgins, Lisa H. Gren, John K. Gohagan, Timothy R. Church, Jeffery Childs, Saundra S. Buys and Karen G. Broski
Affiliation:
Keywords: Cancer screening, collaboration, multidisciplinary, PLCO, randomized controlled trials as subject, team science.
Abstract: Biomedical research cannot succeed without funding, knowledgeable staff, and appropriate infrastructure. There are however equally important but intangible factors that are rarely considered in planning large multidisciplinary endeavors or evaluating their success. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial required extensive collaborations between individuals from many fields, including clinicians, clinical trialists, and administrators; it also addressed questions across the spectrum of cancer prevention and control. In this manuscript, we examine the experiences and opinions of trial staff regarding the building of successful relationships in PLCO. We summarize, in narrative form, data collected using open-ended questionnaires that were administered to the National Cancer Institute project officers, coordinating center staff, screening center principal investigators, and screening center coordinators in 2015, about 3 years after publication of the final primary trial manuscript. Trust, respect, listening to others, and in-person interaction were frequently mentioned as crucial to building successful relationships.
Export Options
About this article
Cite this article as:
Jenkins Victoria, Yurgalevitch Susan, A. Yokochi Lance, Shambaugh Vicki, Reding Douglas, C. Prorok Philip, L. Ogden Sheryl, O’Brien Barbara, Lappe Karen, C. Johnson Christine, M. Marcus Pamela, Jaggi Rachel, Higgins Darlene, H. Gren Lisa, K. Gohagan John, R. Church Timothy, Childs Jeffery, S. Buys Saundra and G. Broski Karen, Building Successful Relationships in the PLCO Cancer Screening Trial, Reviews on Recent Clinical Trials 2015; 10 (3) . https://dx.doi.org/10.2174/1574887110666150731131743
DOI https://dx.doi.org/10.2174/1574887110666150731131743 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger
Current Drug Targets Computational Analysis of the Binding Site(s) of TNF β-TNFR1 Complex: Implications for Designing Novel Anticancer Agents
Clinical Cancer Drugs Dietary Management of Gestational Diabetes Mellitus
Current Nutrition & Food Science Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective
Current Gene Therapy Current Trends in Phyto-cancer Therapy Using Nanoparticles
Current Nanomedicine Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction
Current Protein & Peptide Science Angiogenesis-regulating microRNAs and Ischemic Stroke
Current Vascular Pharmacology The Impact of Folate Status on the Efficacy of Colorectal Cancer Treatment
Current Drug Metabolism Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Current Cancer Therapy Reviews Molecular Mechanisms of Pancreatic Cancer Dissemination: The Role of the Chemokine System
Current Pharmaceutical Design Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options
Recent Patents on Anti-Cancer Drug Discovery Nutritional Programming of Foetal Development: Endocrine Mediators and Long-Term Outcomes for Cardiovascular Health
Current Nutrition & Food Science The Woman’s Heart: Insights into New Potential Targeted Therapy
Current Medicinal Chemistry Adiponectin as a Potential Therapeutic Target for Prostate Cancer
Current Pharmaceutical Design Functional Relevance of Biased Signaling at the Angiotensin II Type 1 Receptor
Endocrine, Metabolic & Immune Disorders - Drug Targets An Unprecedented Revolution in Medicinal Chemistry Driven by the Progress of Biological Science
Current Topics in Medicinal Chemistry Longitudinal Melatonin Production in Female Laboratory Rats During 1997-2006: Possible Modulatory Effects of Changing Solar Activity
Current Aging Science Assessment of Thyroid Disorders and Autoimmunity in Patients with Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Autophagy and Apoptosis Specific Knowledgebases-guided Systems Pharmacology Drug Research
Current Cancer Drug Targets Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry